We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIVE icon
276
Five Below
FIVE
$11.2B
$13.4M 0.07%
76,550
+55,569
+265% +$8.23M
TGNA
277
DELISTED
TEGNA Inc
TGNA
$13.2M 0.07%
942,699
-418,869
-31% -$5.6M
LOW icon
278
Lowe's Companies
LOW
$116B
$13.1M 0.07%
81,871
-259,056
-76% -$42.1M
ROKU icon
279
Roku
ROKU
$21.1B
$13.1M 0.07%
39,549
-125,194
-76% -$32.8M
BFT
280
DELISTED
Foley Trasimene Acquisition Corp. II
BFT
$13.1M 0.07%
+867,570
New +$9.89M
OWLT icon
281
Owlet
OWLT
$153M
$13M 0.07%
+91,504
New +$12.6M
GAP
282
The Gap Inc
GAP
$6.84B
$12.8M 0.07%
+636,273
New +$13.4M
NXPI icon
283
NXP Semiconductors
NXPI
$68B
$12.8M 0.07%
+80,763
New +$11.9M
REYN icon
284
Reynolds Consumer Products
REYN
$5.4B
$12.7M 0.07%
422,058
+257,554
+157% +$7.79M
FNV icon
285
Franco-Nevada
FNV
$41.4B
$12.5M 0.07%
99,863
+52,563
+111% +$7.09M
AMT icon
286
American Tower
AMT
$77.7B
$12.5M 0.07%
55,699
+8,086
+17% +$1.88M
ATRA icon
287
Atara Biotherapeutics
ATRA
$71.2M
$12.4M 0.07%
25,310
+14,323
+130% +$6.61M
IR icon
288
Ingersoll Rand
IR
$33B
$12.3M 0.07%
+270,561
New +$11.2M
ATRC icon
289
AtriCure
ATRC
$1.77B
$12.3M 0.07%
+220,737
New +$9.54M
EDU icon
290
New Oriental
EDU
$7.84B
$12.3M 0.07%
66,092
+61,690
+1,401% +$10.4M
STEM icon
291
Stem
STEM
$49.2M
$12.3M 0.07%
+29,999
New +$7.56M
JD icon
292
JD.com
JD
$40.8B
$12.3M 0.07%
139,426
-63,692
-31% -$5.32M
IPGP icon
293
IPG Photonics
IPGP
$3.89B
$12.2M 0.07%
54,646
+3,625
+7% +$726K
GRUB
294
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$12.2M 0.07%
82,337
-145,874
-64% -$21.6M
ACGL icon
295
Arch Capital
ACGL
$36.1B
$12.1M 0.07%
336,676
+143,899
+75% +$4.72M
KSMT
296
DELISTED
Kismet Acquisition One Corp Ordinary Shares
KSMT
$12.1M 0.07%
+1,178,998
New +$11.6M
FTI icon
297
TechnipFMC
FTI
$30.6B
$12.1M 0.07%
1,733,183
+377,649
+28% +$2.22M
KLIC icon
298
Kulicke & Soffa
KLIC
$5.3B
$12.1M 0.07%
380,996
+34,027
+10% +$991K
CVX icon
299
Chevron
CVX
$388B
$12.1M 0.07%
143,325
+139,328
+3,486% +$11.3M
STE icon
300
Steris
STE
$20.9B
$12.1M 0.07%
63,690
+54,253
+575% +$10.1M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.